[ET Net News Agency, 26 October 2021] Livzon Pharmaceutical Group Inc. (01513) said its
net profit attributable to the shareholders of the company was RMB390.25 million for the
three months ended 30 September 2021, a year-on-year decrease of 6.37%. Basic earnings per
share were RMB0.41.
Operating income was RMB3.13 billion, a year-on-year increase of 10.72%. (RC)